2023
DOI: 10.1016/j.ijpharm.2022.122498
|View full text |Cite
|
Sign up to set email alerts
|

Hydroxytyrosol oleate: A promising neuroprotective nanocarrier delivery system of oleuropein and derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 42 publications
0
5
0
Order By: Relevance
“…Previous studies demonstrated that OLE and HT are not stable in plasma, whereas their metabolites may be found in larger quantities in the circulation after OLE and HT ingestion [ 55 , 56 , 63 , 64 ] and may account for biological effects on PBMCs that might deserve to be tracked [ 50 , 53 , 144 ]. In addition, the data reported in this paper encourage the comparison of these results with those triggered by the administration of more stable/bioavailable formulations of OLE and HT [ 145 , 146 , 147 , 148 ].…”
Section: Discussionmentioning
confidence: 59%
“…Previous studies demonstrated that OLE and HT are not stable in plasma, whereas their metabolites may be found in larger quantities in the circulation after OLE and HT ingestion [ 55 , 56 , 63 , 64 ] and may account for biological effects on PBMCs that might deserve to be tracked [ 50 , 53 , 144 ]. In addition, the data reported in this paper encourage the comparison of these results with those triggered by the administration of more stable/bioavailable formulations of OLE and HT [ 145 , 146 , 147 , 148 ].…”
Section: Discussionmentioning
confidence: 59%
“…Furthermore, a smaller variation in HD values was observed for samples kept at 8 °C for 7 to 60 days. This behavior indicates that these formulations (SNL-BBS-COPA-UR and SLN-W-R) were stable under refrigeration [ 45 , 46 ]. It was also possible to verify the influence of natural bioactives (BBS and COPA) on HD values.…”
Section: Resultsmentioning
confidence: 99%
“…In a very recent study, HT-oleate and its derivative esterified with oleic acid were delivered at low concentrations (0.005-0.1 µM) with solid lipid nanoparticles in SH-SY5Y cells to counter 6-OHDA toxic effects. Results showed that the treatment inhibited the release of ROS, resulting in greater effectiveness than the treatment with non-encapsulated compounds [39]. Recently, two subsequent studies showed that HT restored neuronal functions in cells treated with the neurotoxic pesticide rotenone, used as an experimental model to induce neurotoxicity.…”
Section: Parkinson Modelsmentioning
confidence: 99%